Batch testing update: new batch testing is currently underway for all vials. Testing information →

RETATRUTIDE

£119.99

An investigational engineered peptide studied for combined GIP, GLP-1 and glucagon-receptor signalling.

Batch documentationBatch documentation pending
SKU: AUREN-RETATRUTIDE Category:

Description

Retatrutide, also known as LY3437943, is an engineered peptide designed to activate the GIP, GLP-1 and glucagon receptors. It remains investigational and has not been approved by a medicines regulator for public use.

The molecule is studied in receptor-pharmacology, metabolic and clinical-development programmes. Auren supplies this listing only as a laboratory research material; the page does not describe a dose, route, schedule or expected outcome in a person.

Reviews

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Product record

Decision-ready detail, clearly separated.

Compound identifiers describe the named reference molecule. The actual vial must always be checked against its label, certificate and safety documentation.

01Overview & research context+

Retatrutide, also known as LY3437943, is an engineered peptide designed to activate the GIP, GLP-1 and glucagon receptors. It remains investigational and has not been approved by a medicines regulator for public use.

The molecule is studied in receptor-pharmacology, metabolic and clinical-development programmes. Auren supplies this listing only as a laboratory research material; the page does not describe a dose, route, schedule or expected outcome in a person.

Evidence boundary

Retatrutide is investigational. Research material must not be represented as an approved or substitutable medicinal product.

02Specifications+
Development code
LY3437943
Molecular formula
C221H342N46O68
Molecular weight
4731.3 g/mol
CAS number
2381089-83-2
PubChem CID
171390338
Form
Lyophilised powder

Registry values can differ by salt, counter-ion, hydrate, charge state or supplier representation. The lot certificate takes precedence.

03Storage & laboratory handling+
  1. 01

    Keep the sealed lyophilised material dry, protected from light and tightly closed.

  2. 02

    For longer-term laboratory storage, -20°C is a commonly used condition for peptide reference materials; short-term requirements vary by sequence and formulation.

  3. 03

    After preparing a laboratory solution, minimise time at room temperature and repeated freeze-thaw cycles. The lot-specific label, CoA and SDS take priority over general guidance.

04Documents, sources & common questions+
Current statusBatch documentation pending

No purity, origin or third-party-testing figure is claimed until Auren has a verified report for the specific released lot.